Inicio>>Signaling Pathways>> Metabolism>> Carbohydrate Metabolism>>GSK3β Inhibitor XVIII

GSK3β Inhibitor XVIII

Catalog No.GC18875

An inhibitor of GSK3β

Products are for research use only. Not for human use. We do not sell to patients.

GSK3β Inhibitor XVIII Chemical Structure

Cas No.: 1139875-74-3

Tamaño Precio Disponibilidad Cantidad
1mg
63,00 $
Disponible
5mg
271,00 $
Disponible
10mg
480,00 $
Disponible
25mg
1.052,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of GSK3β Inhibitor XVIII

GSK3β Inhibitor XVIII

Chemical Properties of GSK3β Inhibitor XVIII

Cas No. 1139875-74-3 SDF
Chemical Name [2-chloro-4-[[4-(2-thienyl)-2-pyrimidinyl]amino]phenyl](4-methyl-1-piperazinyl)-, methanone
Canonical SMILES CN1CCN(C(C2=C(Cl)C=C(NC3=NC(C4=CC=CS4)=CC=N3)C=C2)=O)CC1
Formula C20H20ClN5OS M.Wt 413.9
Solubility Soluble in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of GSK3β Inhibitor XVIII

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.416 mL 12.0802 mL 24.1604 mL
5 mM 0.4832 mL 2.416 mL 4.8321 mL
10 mM 0.2416 mL 1.208 mL 2.416 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of GSK3β Inhibitor XVIII

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reseñas

Review for GSK3β Inhibitor XVIII

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GSK3β Inhibitor XVIII

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.